Total Payments
$379,299
2024 Payments
$101,253
Companies
40
Transactions
792
Medicare Patients
1,332
Medicare Billing
$895,438
Payment Breakdown by Category
Other$261,427 (68.9%)
Travel$89,494 (23.6%)
Food & Beverage$20,319 (5.4%)
Education$5,299 (1.4%)
Consulting$2,760 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $261,427 | 145 | 68.9% |
| Travel and Lodging | $89,494 | 243 | 23.6% |
| Food and Beverage | $20,319 | 352 | 5.4% |
| Education | $5,299 | 51 | 1.4% |
| Consulting Fee | $2,760 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $357,169 | 580 | $0 (2024) |
| Arthrex, Inc. | $4,059 | 17 | $0 (2019) |
| UCB SA | $2,760 | 1 | $0 (2021) |
| TREACE MEDICAL CONCEPTS, INC. | $2,426 | 17 | $0 (2022) |
| Life Spine, Inc. | $1,430 | 9 | $0 (2022) |
| Micromed Inc | $1,200 | 1 | $0 (2022) |
| Nexus Spine, LLC | $1,151 | 3 | $0 (2020) |
| Goode Surgical Inc | $925.51 | 8 | $0 (2023) |
| Paragon 28, Inc. | $780.00 | 5 | $0 (2021) |
| DJO, LLC | $724.05 | 7 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $101,253 | 159 | Amgen Inc. ($100,885) |
| 2023 | $138,860 | 256 | Amgen Inc. ($138,477) |
| 2022 | $120,505 | 192 | Amgen Inc. ($117,281) |
| 2021 | $5,838 | 71 | UCB SA ($2,760) |
| 2020 | $3,198 | 44 | Nexus Spine, LLC ($1,151) |
| 2019 | $5,811 | 30 | Arthrex, Inc. ($4,059) |
| 2018 | $3,641 | 34 | Paragon 28, Inc. ($759.94) |
| 2017 | $192.21 | 6 | Pacira Pharmaceuticals Incorporated ($121.49) |
All Payment Transactions
792 individual payment records from CMS Open Payments — Page 1 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Amgen Inc. | EVENITY (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $625.50 | General |
| Category: Bone Health | ||||||
| 12/19/2024 | Amgen Inc. | EVENITY (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $834.00 | General |
| Category: Bone Health | ||||||
| 12/18/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $9.11 | General |
| Category: Bone Health | ||||||
| 11/18/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $26.17 | General |
| Category: Bone Health | ||||||
| 10/17/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $48.54 | General |
| Category: Bone Health | ||||||
| 10/01/2024 | Amgen Inc. | EVENITY (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: Bone Health | ||||||
| 09/26/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: Bone Health | ||||||
| 08/12/2024 | Amgen Inc. | EVENITY (Biological) | Travel and Lodging | Cash or cash equivalent | $387.27 | General |
| Category: Bone Health | ||||||
| 07/25/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $101.75 | General |
| Category: Respiratory | ||||||
| 07/17/2024 | Amgen Inc. | EVENITY (Biological) | Travel and Lodging | Cash or cash equivalent | $756.20 | General |
| Category: Bone Health | ||||||
| 07/17/2024 | Amgen Inc. | EVENITY (Biological) | Travel and Lodging | Cash or cash equivalent | $108.54 | General |
| Category: Bone Health | ||||||
| 07/17/2024 | Amgen Inc. | EVENITY (Biological) | Travel and Lodging | Cash or cash equivalent | $73.73 | General |
| Category: Bone Health | ||||||
| 06/28/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Clinical Trial Product_NMD | ||||||
| 06/27/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: Bone Health | ||||||
| 06/25/2024 | Amgen Inc. | EVENITY (Biological) | Education | In-kind items and services | $7.96 | General |
| Category: Bone Health | ||||||
| 06/25/2024 | Amgen Inc. | EVENITY (Biological) | Education | In-kind items and services | $7.96 | General |
| Category: Bone Health | ||||||
| 06/25/2024 | Amgen Inc. | EVENITY (Biological) | Education | In-kind items and services | $7.96 | General |
| Category: Bone Health | ||||||
| 06/25/2024 | Amgen Inc. | EVENITY (Biological) | Education | In-kind items and services | $7.96 | General |
| Category: Bone Health | ||||||
| 06/20/2024 | Amgen Inc. | EVENITY (Biological) | Travel and Lodging | Cash or cash equivalent | $173.60 | General |
| Category: Bone Health | ||||||
| 06/20/2024 | Amgen Inc. | EVENITY (Biological) | Travel and Lodging | Cash or cash equivalent | $147.82 | General |
| Category: Bone Health | ||||||
| 06/20/2024 | Amgen Inc. | EVENITY (Biological) | Travel and Lodging | Cash or cash equivalent | $110.59 | General |
| Category: Bone Health | ||||||
| 06/20/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | Cash or cash equivalent | $53.27 | General |
| Category: Bone Health | ||||||
| 06/20/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | Cash or cash equivalent | $39.60 | General |
| Category: Bone Health | ||||||
| 06/20/2024 | Amgen Inc. | EVENITY (Biological) | Travel and Lodging | Cash or cash equivalent | $36.18 | General |
| Category: Bone Health | ||||||
| 06/20/2024 | Amgen Inc. | EVENITY (Biological) | Travel and Lodging | Cash or cash equivalent | $36.18 | General |
| Category: Bone Health | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 459 | 44,280 | $1.1M | $436,483 |
| 2022 | 10 | 353 | 29,326 | $769,840 | $276,741 |
| 2021 | 12 | 391 | 15,764 | $538,659 | $168,395 |
| 2020 | 7 | 129 | 161 | $83,180 | $13,819 |
Total Patients
1,332
Total Services
89,531
Medicare Billing
$895,438
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J3111 | Injection, romosozumab-aqqg, 1 mg | Office | 2023 | 34 | 40,530 | $607,950 | $323,459 | 53.2% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 29 | 2,700 | $81,000 | $49,945 | 61.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 118 | 274 | $187,400 | $28,303 | 15.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 77 | 212 | $84,800 | $15,951 | 18.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 52 | 52 | $46,800 | $6,724 | 14.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 23 | 27 | $23,000 | $3,966 | 17.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 20 | 20 | $22,500 | $3,624 | 16.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 71 | 300 | $60,000 | $3,606 | 6.0% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2023 | 17 | 25 | $5,750 | $784.00 | 13.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 18 | 140 | $1,120 | $121.18 | 10.8% |
| J3111 | Injection, romosozumab-aqqg, 1 mg | Office | 2022 | 22 | 27,510 | $412,650 | $207,065 | 50.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 78 | 187 | $112,200 | $20,001 | 17.8% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 12 | 1,080 | $32,400 | $18,649 | 57.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 54 | 153 | $61,200 | $11,103 | 18.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 43 | 50 | $40,000 | $7,145 | 17.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 30 | 30 | $27,000 | $4,246 | 15.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 20 | 20 | $22,500 | $3,429 | 15.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 41 | 223 | $44,600 | $2,710 | 6.1% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2022 | 32 | 48 | $11,040 | $1,529 | 13.9% |
| 73610 | X-ray of ankle, minimum of 3 views | Office | 2022 | 21 | 25 | $6,250 | $864.39 | 13.8% |
| J3111 | Injection, romosozumab-aqqg, 1 mg | Office | 2021 | 13 | 15,120 | $226,800 | $115,693 | 51.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 68 | 132 | $79,200 | $14,622 | 18.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 46 | 68 | $54,400 | $10,638 | 19.6% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 47 | 47 | $52,875 | $8,739 | 16.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 41 | 87 | $34,800 | $6,756 | 19.4% |
About Dr. Candice Brady, DO
Dr. Candice Brady, DO is a Foot and Ankle Surgery healthcare provider based in Camarillo, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/20/2013. The National Provider Identifier (NPI) number assigned to this provider is 1124368667.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Candice Brady, DO has received a total of $379,299 in payments from pharmaceutical and medical device companies, with $101,253 received in 2024. These payments were reported across 792 transactions from 40 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($261,427).
As a Medicare-enrolled provider, Brady has provided services to 1,332 Medicare beneficiaries, totaling 89,531 services with total Medicare billing of $895,438. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Foot and Ankle Surgery
- Other Specialties Foot and Ankle Surgery
- Location Camarillo, CA
- Active Since 02/20/2013
- Last Updated 02/11/2020
- Taxonomy Code 207XX0004X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1124368667
Products in Payments
- EVENITY (Biological) $284,985
- Prolia (Biological) $71,788
- Lapiplasty System (Device) $2,033
- PROLIFT (Device) $1,140
- Gorilla Plating System (Device) $759.94
- DJO Surgical 3DKnee System (Device) $583.27
- Tymlos (Biological) $421.09
- Wegovy (Drug) $373.44
- INFINITY (Device) $349.97
- Triplanar Fixation System (Device) $314.19
- Proclaim Family of SCS IPGs (Device) $302.14
- RELISTOR (Drug) $253.21
- SALVATION (Device) $216.15
- Axium Sheath Braided DRG (Device) $177.39
- GENERAL - PAIN MANAGEMENT (Device) $164.60
- Saturn (Device) $150.00
- Nexus (Device) $148.01
- Saxenda (Drug) $147.08
- COLLAGEN MENISCAL IMPLANT (Device) $140.04
- AQUAMANTYS (Device) $139.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.